Noreen Scheu is a strategic leader with extensive experience in the pharmaceutical and health tech industries. With a proven ability to influence decision-making and drive successful outcomes in highly matrixed environments, Noreen has led cross-functional teams in Commercial, R&D and Business Development. Recognized for clear communication of complex technical information to non-technical audiences, Noreen excels in corporate strategy, business development, market analysis, product development and process improvement. Currently Noreen is supporting combination product and gene therapy start-ups, Alcyone Therapeutics, Regel Therapeutics and Cerebral Therapeutics by developing market valuation models and pitch slides for fundraising.